Literature DB >> 9086141

Genetic and antigenic diversity of Ehrlichia chaffeensis: comparative analysis of a novel human strain from Oklahoma and previously isolated strains.

S M Chen1, X J Yu, V L Popov, E L Westerman, F G Hamilton, D H Walker.   

Abstract

A new Ehrlichia strain, designated as Ehrlichia chaffeensis, Sapulpa strain, was isolated from a patient from Oklahoma with severe ehrlichiosis. Isolation of the ehrlichial pathogen was achieved by inoculating patient blood onto HEL cells and DH82 cells. Antigenic properties of the new isolate were characterized with monoclonal antibodies, homologous patient serum, and polyclonal rabbit serum by Western immunoblotting. The results showed antigenic differences and protein size variation of Sapulpa strain compared with the other 2 strains of E. chaffeensis. Sequencing of the 16S rRNA gene showed 100% identity to that of E. chaffeensis, strain 91HE17. Polymerase chain reaction and sequencing of DNA homologous to the 120-kDa protein gene of E. chaffeensis, Arkansas strain, showed that this gene of Sapulpa strain was smaller than that of Arkansas strain and contained a repeat region with three tandem repeat units.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086141     DOI: 10.1086/513982

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.

Authors:  C D Paddock; J W Sumner; G M Shore; D C Bartley; R C Elie; J G McQuade; C R Martin; C S Goldsmith; J E Childs
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Molecular cloning and characterization of the 120-kilodalton protein gene of Ehrlichia canis and application of the recombinant 120-kilodalton protein for serodiagnosis of canine ehrlichiosis.

Authors:  X J Yu; J W McBride; C M Diaz; D H Walker
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation.

Authors:  J W Sumner; J E Childs; C D Paddock
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis.

Authors:  S M Chen; L C Cullman; D H Walker
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis.

Authors:  X J Yu; P A Crocquet-Valdes; L C Cullman; V L Popov; D H Walker
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis.

Authors:  X J Yu; J W McBride; D H Walker
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

7.  Enzyme-linked immunosorbent assay with conserved immunoreactive glycoproteins gp36 and gp19 has enhanced sensitivity and provides species-specific immunodiagnosis of Ehrlichia canis infection.

Authors:  Ana Maria Cárdenas; C Kuyler Doyle; Xiaofeng Zhang; Kimberly Nethery; Richard E Corstvet; David H Walker; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2006-12-06

8.  Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family.

Authors:  N Ohashi; N Zhi; Y Zhang; Y Rikihisa
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 9.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Defining the immune response to Ehrlichia species using murine models.

Authors:  Stephen K Chapes; Roman R Ganta
Journal:  Vet Parasitol       Date:  2008-10-17       Impact factor: 2.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.